샘플 요청 목록

 카트 문의
시장보고서
상품코드
1744783

세계의 기계적 순환 보조 기기 시장

Mechanical Circulatory Support Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 284 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

기계적 순환 보조 기기 세계 시장은 2030년까지 14억 달러에 달할 전망

2024년에 12억 달러로 추정되는 기계적 순환 보조 기기 세계 시장은 2030년에는 14억 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 3.1%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 심실보조기기는 CAGR 2.3%를 기록하며 분석 기간 종료시에는 6억 4,800만 달러에 달할 것으로 예측됩니다. 체외식막 산소요법 부문의 성장률은 분석 기간 동안 CAGR 4.4%로 추정됩니다.

미국 시장은 3억 1,920만 달러, 중국은 CAGR 5.7%로 성장 예측

미국의 기계적 순환 보조 기기 시장은 2024년에 3억 1,920만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년 분석 기간 동안 CAGR 5.7%로 성장하여 2030년에는 2억 7,470만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.3%와 2.3%로 예측됩니다. 유럽에서는 독일이 CAGR 1.7%로 성장할 것으로 예측됩니다.

세계의 기계적 순환 보조 기기 시장 - 주요 동향과 촉진요인 정리

기계식 순환 보조 기기가 심부전 치료에 혁명을 일으키는 이유는 무엇인가?

기계적 순환 보조 기기(MCS)는 심부전이 진행된 환자에서 기능 장애가 발생한 심장의 펌프 기능을 지원하거나 대체하기 위해 고안된 생명을 구하는 기술입니다. 심실보조순환기기(VAD), 인공심장(TAH), 체외막산소요법(ECMO) 시스템을 포함한 이러한 기기들은 약물 치료가 더 이상 충분하지 않을 때 이식을 위한 가교, 회복을 위한 가교, 또는 목적 치료로 사용됩니다. 심장 이식을 기다리는 환자나 비가역적 심기능 저하를 관리하는 환자의 삶의 질을 높이는데 중요한 역할을 하고 있습니다.

소형화, 생체적합성, 장기 이식 가능성 등의 발전으로 MCS의 적응증은 연령과 합병증에 관계없이 확대되고 있습니다. 이식이 불가능한 말기 심부전 환자에게 MCS는 순환기능을 유지하고 이동성과 독립성을 향상시키는 장기적인 치료 옵션입니다. 인구 고령화, 허혈성 심질환, 심근병증으로 인한 심부전 유병률 증가가 MCS 기술에 대한 세계 임상 수요를 주도하고 있습니다.

공학적인 발전과 임상적 통합은 어떻게 기기의 유용성을 향상시키고 있는가?

최근 기계공학 및 재료공학의 발전은 더 작고 내구성이 뛰어나며 혈전증, 출혈, 감염 등의 합병증이 적은 차세대 보조 인공심장 개발로 이어지고 있습니다. 연속 흐름 펌프, 자기 부상식 임펠러 및 무선 에너지 전송 시스템은 수술 부담을 줄이면서 혈역학적인 안정성을 개선하여 환자 결과를 재정의하고 있습니다. 웨어러블 드라이브 라인 시스템과 완전 이식형 프로토타입은 환자의 이동성과 삶의 질을 개선하고 외래 관리 및 장기 사용을 용이하게 합니다.

임상적 측면에서는 실시간 혈역학 모니터링, 원격 원격 측정, AI를 통한 데이터 해석의 통합을 통해 의사결정과 이식 후 관리를 강화합니다. 외과의사, 순환기내과 전문의, 재활의학과 전문의가 포함된 다학제적 심부전 팀이 첨단 영상 진단 및 위험도 분류 도구에 기반한 환자 맞춤형 MCS 프로토콜을 도입하고 있습니다. 이러한 전반적인 개선으로 입원 기간이 단축되고 회복 결과가 개선되어 전 세계 3차 의료기관에서 채택이 확대되고 있습니다.

도입을 주도하고 있는 의료기관과 환자층은?

심흉부외과 센터, 대학병원, 심부전 프로그램 등이 MCS 기기의 주요 채택자입니다. 심장 이식 프로그램이 확립된 미국, 유럽, 일본에서는 이식 전 치료와 목적지 치료 모두에서 MCS 기기의 사용이 증가하고 있습니다. 소아심장센터에서는 선천성 심장병 및 소아 심근증용으로 설계된 소형화된 MCS 시스템이 채택되고 있으며, 신흥국에서는 가역적 심부전 및 호흡부전에 대한 ECMO 시스템이 중환자실에 도입되고 있습니다.

응급 및 외상 현장에서도 수요가 증가하고 있으며, 심정지 환자를 지원하고 중요한 중재를 연결하기 위해 휴대용 에크모 유닛이 배치되고 있습니다. 전 세계 심장 수술 프로그램, 특히 고소득 국가에서 통합 심혈관 치료 전략의 일환으로 MCS에 대한 투자가 증가하고 있습니다. 심부전이 전 세계적으로 이환율과 사망률의 주요 원인이 되고 있는 만큼, 다양한 의료 현장에서 기계적 보조기기에 대한 수요가 증가할 것으로 예상됩니다.

기계식 순환 보조 기기 시장의 성장은 몇 가지 요인에 의해 주도됩니다...

기계적 순환 보조 기기 시장의 성장 원동력은 만성 심부전 및 말기 심부전 유병률 증가, 기기의 소형화, 이식 및 중환자 치료에서 보조 인공심장 및 ECMO의 임상적 채택 확대입니다. 심장 이식 대기 환자의 증가와 장기 기증자 부족으로 인해 장기적인 기계적 보조기기에 대한 수요가 증가하고 있습니다. 임상 가이드라인은 MCS를 통한 조기 개입을 권장하고 있으며, 환자 선택과 퇴원 후 프로토콜의 개선으로 결과가 개선되고 있습니다.

생체적합성 재료, 무선 전력 시스템, 완전 이식형 기기에 대한 투자가 기술 혁신을 주도하고 있으며, 의료 시스템은 심부전 관리 인프라에 자원을 할당하고 있습니다. 소아 심장병학 및 외상 치료의 새로운 응용 분야도 새로운 사용 사례를 창출하고 있습니다. 또한, 정부 자금 지원, FDA의 조기 임상시험 지정, 산학 협력은 제품 개발 파이프라인을 가속화하여 MCS 기술의 장기적인 세계 시장 확장을 보장하고 있습니다.

부문

제품(보조 인공 심장, 체외식막산소 주입기, 대동맥내 풍선 펌프, 인공심장), 최종사용(병원, 심장병 센터, 외래 수술 센터, 전문 센터)

조사 대상 기업 사례(총 41개사)

  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • BiVACOR Inc.
  • Braile Biomedica Ltd.
  • CardiacAssist, Inc.
  • CardioBridge GmbH
  • Carmat SA
  • Eurosets S.r.l.
  • Getinge AB
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • Medtronic plc
  • MicroMed Cardiovascular, Inc.
  • ReliantHeart, Inc.
  • St. Jude Medical, Inc.
  • Sun Medical Technology Research Corp.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Corporation

관세 영향 계수

Global Industry Analysts는 본사 소재지, 생산기지, 수출입(완제품 및 OEM)에 따른 기업의 경쟁력 변화를 예측하고 있으며, 이번 보고서에는 지리적 시장에 대한 관세의 영향을 반영하였습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 판매 비용 증가, 수익성 감소, 공급망 재구성 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사에게 영향을 미칠 것으로 예상됩니다.

Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사하고 있습니다.

Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.

2025년 4월 : 협상 단계

이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.

2025년 7월 : 최종 관세 재설정

각국의 최종 리셋이 발표되는 7월에도 고객님들께 무료 업데이트를 제공할 예정입니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.

상호 및 양자 간 무역과 관세의 영향 분석:

미국 <> 중국 <> 멕시코 <> 캐나다 <> EU <> 일본 <> 인도 <> 기타 176개국

업계 최고의 이코노미스트 : Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량경제 상황에서 이 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트 그룹을 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정이 적용되어 있습니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.06.20

Global Mechanical Circulatory Support Devices Market to Reach US$1.4 Billion by 2030

The global market for Mechanical Circulatory Support Devices estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Ventricular Assist Devices, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$648.0 Million by the end of the analysis period. Growth in the Extracorporeal Membrane Oxygenation segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$319.2 Million While China is Forecast to Grow at 5.7% CAGR

The Mechanical Circulatory Support Devices market in the U.S. is estimated at US$319.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$274.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Mechanical Circulatory Support Devices Market - Key Trends & Drivers Summarized

Why Are Mechanical Circulatory Support Devices Revolutionizing Heart Failure Treatment?

Mechanical circulatory support (MCS) devices are life-saving technologies designed to support or replace the pumping function of the failing heart in patients with advanced heart failure. These devices-including ventricular assist devices (VADs), total artificial hearts (TAHs), and extracorporeal membrane oxygenation (ECMO) systems-are used as bridge-to-transplant, bridge-to-recovery, or destination therapy in cases where pharmacologic management is no longer sufficient. They play a crucial role in improving survival rates, stabilizing patients during critical periods, and enhancing quality of life for those awaiting cardiac transplants or managing irreversible cardiac decline.

Advances in miniaturization, biocompatibility, and long-term implantability have expanded the indications for MCS use across age groups and comorbidities. For end-stage heart failure patients ineligible for transplant, MCS devices offer a viable long-term treatment option that sustains circulatory function and improves mobility and independence. The increasing prevalence of heart failure due to aging populations, ischemic heart disease, and cardiomyopathies is driving the global clinical demand for MCS technologies.

How Are Engineering Advances and Clinical Integration Enhancing Device Utility?

Recent innovations in mechanical and materials engineering have led to the development of next-generation VADs that are smaller, more durable, and less prone to complications like thrombosis, bleeding, or infection. Continuous-flow pumps, magnetically levitated impellers, and wireless energy transfer systems are redefining patient outcomes by improving hemodynamic stability with reduced surgical burden. Wearable driveline systems and fully implantable prototypes are improving patient mobility and quality of life, facilitating outpatient management and long-term use.

On the clinical front, integration of real-time hemodynamic monitoring, remote telemetry, and AI-assisted data interpretation is enhancing decision-making and post-implantation care. Multidisciplinary heart failure teams, including surgeons, cardiologists, and rehabilitation specialists, are implementing patient-tailored MCS protocols supported by advanced imaging and risk stratification tools. These systemic improvements are reducing hospitalization time, improving recovery outcomes, and expanding adoption in tertiary care centers worldwide.

Which Healthcare Settings and Patient Segments Are Leading Adoption?

Cardiothoracic surgical centers, academic hospitals, and advanced heart failure programs are the primary adopters of MCS devices. In the U.S., Europe, and Japan, where cardiac transplant programs are well established, MCS devices are increasingly used as both pre-transplant and destination therapy. Pediatric cardiac centers are adopting miniaturized MCS systems designed for congenital heart disease and pediatric cardiomyopathies, while emerging economies are deploying ECMO systems in critical care units for reversible cardiac or respiratory failure.

Demand is also growing in emergency and trauma settings, where portable ECMO units are deployed to support cardiac arrest patients or bridge critical interventions. Global cardiac surgery programs, especially in high-income nations, are investing in MCS as part of integrated cardiovascular care strategies. As heart failure becomes a leading cause of morbidity and mortality worldwide, demand for mechanical support devices is expected to rise across a broad spectrum of care settings.

The Growth in the Mechanical Circulatory Support Devices Market Is Driven by Several Factors…

The growth in the mechanical circulatory support devices market is driven by increasing prevalence of chronic and end-stage heart failure, advances in device miniaturization, and expanded clinical adoption of VADs and ECMO in transplant and critical care. Rising numbers of patients awaiting heart transplants, coupled with donor organ shortages, are fueling demand for long-term mechanical support. Clinical guidelines are increasingly endorsing early intervention with MCS, while better patient selection and post-discharge protocols are improving outcomes.

Investments in biocompatible materials, wireless power systems, and fully implantable devices are driving innovation, while healthcare systems are allocating resources to heart failure management infrastructure. Emerging applications in pediatric cardiology and trauma care are also creating new use cases. Furthermore, government funding, FDA fast-track designations, and academic-industry partnerships are accelerating product development pipelines-ensuring long-term global market expansion for MCS technologies.

SCOPE OF STUDY:

The report analyzes the Mechanical Circulatory Support Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps, Artificial Heart); End-Use (Hospitals, Cardiology Centers, Ambulatory Surgery Centers, Specialty Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • BiVACOR Inc.
  • Braile Biomedica Ltd.
  • CardiacAssist, Inc.
  • CardioBridge GmbH
  • Carmat SA
  • Eurosets S.r.l.
  • Getinge AB
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • Medtronic plc
  • MicroMed Cardiovascular, Inc.
  • ReliantHeart, Inc.
  • St. Jude Medical, Inc.
  • Sun Medical Technology Research Corp.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Mechanical Circulatory Support Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of End-Stage Heart Failure Globally Drives Demand for Mechanical Circulatory Support (MCS) Devices
    • Growing Preference for Ventricular Assist Devices (VADs) as Bridge-to-Transplant Solutions Expands Clinical Adoption
    • Advancements in Miniaturization and Wireless Power Transfer Strengthen the Case for Next-Generation Implantable MCS Systems
    • Improved Patient Survival Rates With Long-Term LVAD Use Encourage Wider Use in Destination Therapy Applications
    • Expansion of Advanced Heart Failure Programs in Hospitals Boosts Institutional Investment in MCS Infrastructure
    • Rising Number of Heart Transplant Candidates Highlights Demand for Durable Bridge-to-Transplant Support Systems
    • OEM Focus on Fully Implantable and Percutaneous Systems Enhances Patient Mobility and Reduces Infection Risks
    • Integration of Remote Monitoring and Telehealth Capabilities Supports Post-Implant Management and Reduces Readmissions
    • Government Reimbursement Policies and Public Health Coverage Expand Patient Access to MCS Devices in Developed Markets
    • Clinical Research Demonstrating Improved Quality of Life Fuels Physician Confidence in Prescribing MCS Therapies
    • Increasing Use of MCS in Pediatric and Congenital Heart Disease Applications Creates New Niche Markets
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Mechanical Circulatory Support Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Mechanical Circulatory Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ventricular Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ventricular Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Ventricular Assist Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Extracorporeal Membrane Oxygenation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Extracorporeal Membrane Oxygenation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Intra-Aortic Balloon Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Intra-Aortic Balloon Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Intra-Aortic Balloon Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Artificial Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cardiology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cardiology Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Specialty Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Specialty Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Specialty Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Mechanical Circulatory Support Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Mechanical Circulatory Support Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Mechanical Circulatory Support Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제